MBBS

Biotechnology Industry Research Assistance Council is a not-for-profit Section 8, Schedule B, Public Sector Enterprise, under Department of Biotechnology (DBT), Government of India as an Interface Agency to strengthen and empower the emerging Biotech enterprise to undertake strategic research and innovation, addressing nationally relevant product development needs.

Indoco Remedies Ltd., is a fully integrated, research-oriented pharma company engaged in the manufacturing and marketing of Formulations and Active Pharmaceutical Ingredients (APIs). We have seven decades of presence in the Indian Pharma market and a strong foothold in the international market across 55 countries. Indoco, a USD 166 million company, employs around 6000 personnel, including over 300 skilled scientists.

Post : Group Product Manager / Sr. Product Manager

The Institute of Liver & Biliary Sciences (ILBS) has been established by the Government of the National Capital Territory of Delhi as an autonomous institute, under the Societies act. The mission of ILBS is to become a dedicated international centre of excellence for the diagnosis, management and advanced training and research in the field of liver and biliary diseases.  The first phase of ILBS is already functional having 180 hospital beds, 74 of which cater as intensive care (ICU) beds.

Since its establishment in the year 1998, Panexcell Clinical Lab Private Limited has made successful inroads across the clinical research sector. Formerly known as Drug Monitoring Research Institute Private Limited, it started off in Sion, Mumbai in a 800+ SQM facility with a single HPLC (High Performance Liquid Chromatography) and a four member team. Banking on their continued success, Panexcell shifted to a bigger facility in Rabale, Navi Mumbai.

ICMR-NARI is located at Bhosari, Pune on a seven acre plot. Since its inception the Institute has ably supported the National AIDS Control Programme, especially in the areas of surveillance, capacity building, laboratory services and drug resistance studies. ICMR-NARI derives strength from wide ranging National and International Collaborations.  The Institutes research activities are guided by a Scientific Advisory Committee which includes eminent scientists from varied disciplines.

National Agri-Food Biotechnology Institute (NABI), Mohali is inviting applications from motivated students for admission to the PhD degree program in Biotechnology for the August-September 2023 session. NABI is recognized as a centre by the Regional Centre for Biotechnology (RCB), Faridabad, for conducting PhD (Biotechnology) programs. The program will be conducted at NABI, and the degree will be awarded by RCB, an institute of national importance established through an act of parliament.

Tata AIA Life Insurance Company Limited (Tata AIA Life) is a joint venture company, formed by Tata Sons Pvt. Ltd. and AIA Group Ltd. (AIA). Tata AIA Life combines Tata’s pre-eminent leadership position in India and AIA’s presence as the largest, independent listed pan-Asian life insurance group in the world spanning 18 markets in the Asia Pacific region. Tata AIA Life has written retail new business weighted premium of Rs. 2,692 crore for the financial year 2019-20.

AIIMS Raipur is one of the SIX AIIMS healthcare institutes being established by the Ministry of Health & Family Welfare, Government of India under the Pradhan Mantri Swasthya Suraksha Yojna (PMSSY). With the aim of correcting regional imbalances in quality tertiary level healthcare in the country, and attaining self sufficiency in graduate and postgraduate medical education and training the PMSSY planned to set up 6 new AIIMS like institutions in under served areas of the country.

Founded in 1849, Pfizer is the world's premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.